Biosynex Stock Price To Earnings To Growth
| ALBIO Stock | EUR 2.62 0.02 0.77% |
Biosynex fundamentals help investors to digest information that contributes to Biosynex's financial success or failures. It also enables traders to predict the movement of Biosynex Stock. The fundamental analysis module provides a way to measure Biosynex's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biosynex stock.
Biosynex |
Biosynex Company Price To Earnings To Growth Analysis
Biosynex's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Biosynex has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all France stocks is 100.0% higher than that of the company.
Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Biosynex Fundamentals
| Return On Equity | 0.89 | |||
| Return On Asset | 0.45 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 91.77 M | |||
| Shares Outstanding | 10.25 M | |||
| Shares Owned By Insiders | 58.06 % | |||
| Shares Owned By Institutions | 1.58 % | |||
| Price To Earning | 48.98 X | |||
| Price To Book | 0.77 X | |||
| Price To Sales | 0.46 X | |||
| Revenue | 382.53 M | |||
| Gross Profit | 206.41 M | |||
| EBITDA | 139.33 M | |||
| Net Income | 104 M | |||
| Cash And Equivalents | 1.98 M | |||
| Cash Per Share | 0.22 X | |||
| Total Debt | 29.16 M | |||
| Debt To Equity | 17.70 % | |||
| Current Ratio | 1.94 X | |||
| Book Value Per Share | 17.24 X | |||
| Cash Flow From Operations | 109.83 M | |||
| Earnings Per Share | 6.37 X | |||
| Target Price | 37.0 | |||
| Number Of Employees | 320 | |||
| Beta | -2.01 | |||
| Market Capitalization | 121.6 M | |||
| Total Asset | 268.94 M | |||
| Retained Earnings | (5 M) | |||
| Working Capital | 2 M | |||
| Current Asset | 6 M | |||
| Current Liabilities | 4 M | |||
| Z Score | 3.4 | |||
| Annual Yield | 0.17 % | |||
| Net Asset | 268.94 M | |||
| Last Dividend Paid | 2.0 |
About Biosynex Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biosynex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biosynex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biosynex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biosynex Stock Analysis
When running Biosynex's price analysis, check to measure Biosynex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosynex is operating at the current time. Most of Biosynex's value examination focuses on studying past and present price action to predict the probability of Biosynex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosynex's price. Additionally, you may evaluate how the addition of Biosynex to your portfolios can decrease your overall portfolio volatility.